If you or a loved one are battling a blood cancer like chronic myelomonocytic leukemia (CMML), it is important to understand the different aspects that may impact your journey to recovery, such as the type of insurance you have. Dr. Kingsley Nnawub of the University of Arkansas for Medical Sciences Northwest Regional Campus shared his research findings at the recent ASH 2023 conference. These findings demonstrate how the type of insurance a patient has impacts their survival outcomes and the quality of care they receive. Watch his interview or read the summary of his findings below.
Dr. Nnawub's research focused on blood cancer patients in Arkansas, analyzing medical record data from 2013 to 2022. His team reviewed over 2,400 patients' records, assessing how different insurance types influenced their survival outcomes and the quality of care they received.
As a patient battling CMML, this information is invaluable. It highlights the need to understand your insurance policy and its limitations or advantages. Here are some ways this study can be useful to you:
The journey through CMML treatment can be complex and multifaceted. This study is a reminder that your insurance type is more than just a way to pay for treatment; it's a crucial element that can influence your overall care and prognosis. As you navigate this path, keep in mind the importance of understanding all aspects of your treatment, including insurance.
Remember, you're not alone in this fight. Your healthcare team, including doctors, nurses, and patient advocates, can provide guidance and support. Don't hesitate to ask questions and seek the best possible care for your unique situation.
In conclusion, Dr. Nnawub's study shares important insight about the critical role of insurance in cancer treatment outcomes. As a patient, being informed and proactive about your insurance can make a significant difference in your treatment journey. Stay empowered, and remember that every step you take is a step towards recovery and better health.
If you or a loved one are battling a blood cancer like chronic myelomonocytic leukemia (CMML), it is important to understand the different aspects that may impact your journey to recovery, such as the type of insurance you have. Dr. Kingsley Nnawub of the University of Arkansas for Medical Sciences Northwest Regional Campus shared his research findings at the recent ASH 2023 conference. These findings demonstrate how the type of insurance a patient has impacts their survival outcomes and the quality of care they receive. Watch his interview or read the summary of his findings below.
Dr. Nnawub's research focused on blood cancer patients in Arkansas, analyzing medical record data from 2013 to 2022. His team reviewed over 2,400 patients' records, assessing how different insurance types influenced their survival outcomes and the quality of care they received.
As a patient battling CMML, this information is invaluable. It highlights the need to understand your insurance policy and its limitations or advantages. Here are some ways this study can be useful to you:
The journey through CMML treatment can be complex and multifaceted. This study is a reminder that your insurance type is more than just a way to pay for treatment; it's a crucial element that can influence your overall care and prognosis. As you navigate this path, keep in mind the importance of understanding all aspects of your treatment, including insurance.
Remember, you're not alone in this fight. Your healthcare team, including doctors, nurses, and patient advocates, can provide guidance and support. Don't hesitate to ask questions and seek the best possible care for your unique situation.
In conclusion, Dr. Nnawub's study shares important insight about the critical role of insurance in cancer treatment outcomes. As a patient, being informed and proactive about your insurance can make a significant difference in your treatment journey. Stay empowered, and remember that every step you take is a step towards recovery and better health.
about the author
Megan Heaps
Megan joined HealthTree in 2022. As a writer and daughter of a blood cancer patient, she is dedicated to helping patients and their caregivers understand the various aspects of their disease. This understanding enables them to better advocate for themselves and improve their treatment outcomes. In her spare time, she enjoys spending time with her family, sewing, and cooking.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.